All In Biotech

Drug Trial Radar · NCT07677059

A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study

A Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Safety and Tolerability of KT-621 in Participants With Asthma Previously Enrolled in a KT-621 Asthma Study

Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

264

Planned (sponsor's estimate)

Start

Jun 25, 2026

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Kymera Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jun 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 2b open-label, long-term extension study is designed to evaluate the long-term safety and efficacy of KT-621 in participants with asthma who were previously enrolled in the parent study (KT621-AS-202) of KT-621 for asthma. The main goals of this study are to investigate the long-term safety and tolerability of KT-621, the long-term efficacy of KT-621 at treating asthma, and how KT-621 behaves in the body long-term.

Conditions

  • Asthma (Diagnosis)

Interventions

  • KT-621Drug

    Oral drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment-emergent adverse events (TEAEs)Time frame: From baseline through Week 52
  2. Incidence of treatment-emergent serious adverse events (SAEs)Time frame: From baseline through Week 52

Locations

7 sites in 4 countries. Site status is shown where the registry gives one.

  • Kymera Investigative Site

    Miami, Florida · Recruiting

  • Kymera Investigative Site

    Tampa, Florida · Recruiting

  • Kymera Investigative Site

    Dallas, Texas · Recruiting

  • Kymera Investigative Site

    Berlin, Germany · Recruiting

  • Kymera Investigative Site

    Poznan, Poland · Recruiting

  • Kymera Investigative Site

    Kamenitz, Serbia · Recruiting

  • Kymera Investigative Site

    Užice, Serbia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.